|
⚲
|
| Keyboard |
| David Tanen | |
|---|---|
| Firm | |
| Address | 689 Fifth Avenue 12th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Iconovir Bio Inc | 021-484703 | Executive Officer | 20.2 M of 20.2 M |
||
| 76Bio Inc | 021-473359 | Director | 12.2 M of 12.2 M |
||
| 76Bio Inc | 021-428624 | Executive Officer | 10.0 M of 10.0 M |
||
| Torrey View LLC | 021-387472 | Executive Officer | 0.1 M of 0.1 M |
||
| Iconovir Bio Inc | 021-383121 | Executive Officer | 77.0 M of 77.0 M |
||
| Neogene Therapeutics Inc | 021-375460 | Director | 110.0 M of 110.0 M |
||
| Kronos Bio Inc | 021-344261 | Executive Officer | 105.0 M of 105.0 M |
||
| Neogene Therapeutics Inc | 021-340287 | Director | 15.0 M of 15.0 M |
||
| Kronos Bio Inc | 021-313896 | Executive Officer | 18.0 M of 18.0 M |
||
| Allogene Therapeutics Inc | 021-310557 | Executive Officer | 411.8 M of 411.8 M |
||
| Veterinary Prime Inc | 021-280782 | Director | 4.3 M of 6.6 M |
||
| Arno Therapeutics Inc | 021-269798 | Director | 4.5 M of 4.5 M |
||
| Arno Therapeutics Inc | 021-206264 | Director | 30.8 M of 30.8 M |
||
| Arno Therapeutics Inc | 021-187911 | Director | 11.1 M of 18.4 M |
||
| Arno Therapeutics Inc | 021-148137 | Executive Officer | 8.4 M of 13.2 M |
||
| Nile Therapeutics Inc | 021-109193 | Executive Officer | 2.3 M of 3.0 M |
||